Synapse

← Cancer Research Communications

Papers in Cancer Research Communications

Page 4 · newest first

  1. Mapping genomic heterogeneity in paediatric and adolescent-young adult sarcomas: insights from the Italian SAR-GEN2016 and SAR-GEN_ITA prospective multicenter trialsCancer Research Communications · 2026
  2. Editor’s Note: The Genetic Landscape of Ocular Adnexa MALT Lymphoma Reveals Frequent Aberrations in NFAT and MEF2B Signaling PathwaysCancer Research Communications · 2026
  3. Single cell RNA analysis of murine osteosarcoma uncovers Skp2 function in metastasis, genomic instability and immune activation and reveals additional target pathwayCancer Research Communications · 2026
  4. Cell-free DNA-derived immune cell ratios uncover cancer-associated systemic changesCancer Research Communications · 2026
  5. Real-world characterization and treatment patterns of patients with desmoid tumors at an academic center in the United StatesCancer Research Communications · 2026
  6. Characterization of mitochondrial double-stranded RNA levels in Non-Small Cell Lung CarcinomaCancer Research Communications · 2026
  7. Predominant Merkel Cell Polyomavirus DNA Detection in Essential Thrombocythemia within Myeloproliferative NeoplasmsCancer Research Communications · 2026
  8. Metastasis-associated wound repair promotes reciprocal lung epithelium activation and breast cancer metastatic outgrowthCancer Research Communications · 2026
  9. Constitutive EGFR activation induced by PTPRR downregulation confers resistance to KRAS inhibitorsCancer Research Communications · 2026
  10. Pseudogene co-expression networks reveal a robust prognostic signature for pediatric B-ALL survivalCancer Research Communications · 2026
  11. A phase I study of hydroxychloroquine and suba-itraconazole in men with biochemical relapse of prostate cancer (HITMAN-PC): dose escalation resultsCancer Research Communications · 2026
  12. The KRAS-variant and cetuximab in HPV-positive oropharyngeal cancer – results from the NRG/RTOG 1016 trialCancer Research Communications · 2026
  13. Mechanisms Underlying Cedazuridine-Mediated Enhancement of Oral Decitabine BioavailabilityCancer Research Communications · 2026
  14. Phase 1 Study of INBRX-105, a TNFRSF9 (4-1BB) and PD-L1 Bispecific Antibody, in Patients with Select Solid TumorsCancer Research Communications · 2026
  15. Lenvatinib Plus Pembrolizumab for Patients With Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results From the Phase 2 LEAP-005 StudyCancer Research Communications · 2026
  16. Mutant Isocitrate dehydrogenase 1 sensitizes intrahepatic cholangiocarcinoma cells to MDM2 inhibitorsCancer Research Communications · 2026
  17. Social risk burden among U.S. cancer survivors across adulthood: Evidence from the 2022–2023 BRFSSCancer Research Communications · 2026
  18. Impact of Hepatitis B Virus Infection on the Efficacy and Safety of Pembrolizumab Plus Chemotherapy for Advanced Biliary Tract Cancer in the KEYNOTE-966 StudyCancer Research Communications · 2026
  19. LSD1 Performs Demethylase-Independent and Context-Specific Roles in Ewing SarcomaCancer Research Communications · 2026
  20. Subclassification of Small Cell Lung Cancer Based on Gene Expression Signatures and Machine LearningCancer Research Communications · 2026
  21. Nanobody-Engineered CLL-1 CAR-T Cells: Optimizing Tumor-Specific Cytotoxicity and Minimizing Off-Tumor ToxicityCancer Research Communications · 2026
  22. Prevalence and correlates of sleep difficulties in a large multicenter outpatient oncology population as identified through practice-based screeningCancer Research Communications · 2026
  23. Diagnostic Outcomes Among Patients with Positive Multi-Cancer Early Detection Test ResultsCancer Research Communications · 2026
  24. Ancestrally diverse autologous patient-derived organoid – immune cell co-culture platform for addressing immunotherapeutic outcome disparities in high-grade endometrial cancerCancer Research Communications · 2026
  25. Collagen-bearing exosomes from breast cancer-associated fibroblasts promote T cell dysfunctionCancer Research Communications · 2026
  26. 3D “emboli” culture models epithelial breast cancer cell oxidative mitochondrial metabolism with relevance for lung metastasisCancer Research Communications · 2026
  27. BRAFV600E Expression in c-Kit+ Interstitial Cells of Cajal Drives Gastrointestinal Stromal Tumor Formation in MiceCancer Research Communications · 2026
  28. Examining the Intersection between Drivers of Disparities: Beyond Place – Social Determinants and Stress Reactivity in African American Breast Cancer SurvivorsCancer Research Communications · 2026
  29. Weight Loss Patterns and Clinical Outcomes of GLP1 Receptor Agonists in Breast Cancer SurvivorsCancer Research Communications · 2026
  30. Neutrophil Antigen Presentation Reprograms the Tumor Microenvironment and Elicits Durable and Broad Anti-Tumor ImmunityCancer Research Communications · 2026
  31. A classifier for patient-derived colorectal tumoroid drug sensitivity using confocal imaging and growth rate inhibition metricsCancer Research Communications · 2026
  32. Identification of a Cytokine Biomarker for Prognostic Modeling of Breast Cancer-Related LymphedemaCancer Research Communications · 2026
  33. Functionally characterizing the renal cell carcinoma tumor immune microenvironment via patient-derived ex vivo modelsCancer Research Communications · 2026
  34. The MATTERS Trial: Safety and Tolerability of Whole-Body Hyperthermia at 41.50°C in Combination with Chemotherapy in Metastatic Cancer PatientsCancer Research Communications · 2026
  35. ZSTK3744, a novel aryl hydrocarbon receptor agonist, exhibits efficacy against chemotherapy-resistant triple-negative breast cancerCancer Research Communications · 2026
  36. CLDN6 Expression Plasticity in Ovarian Cancer: Insights into Therapeutic Optimization for CLDN6-Targeted ImmunotherapyCancer Research Communications · 2026
  37. ANGPTL3 in the peripheral circulation is associated with resistance to anti-PD1 therapy in advanced gastric cancerCancer Research Communications · 2026
  38. m6A modification of ATOX1 inhibits acute myeloid leukemia progression by promoting cuproptosisCancer Research Communications · 2026
  39. Effect of Liver Metastases on Survival in Microsatellite-Stable Metastatic Colorectal Cancer Treated with Immune Checkpoint InhibitorsCancer Research Communications · 2026
  40. Novel syngeneic cell lines for studying high-risk BRAFV600E-driven colorectal cancer in vivoCancer Research Communications · 2026
  41. Comparative analysis of cell-free DNA fragmentation patterns in canines with sarcoma and tumor-free canines and humansCancer Research Communications · 2026
  42. Surface Marker Identification to Capture Live Circulating Tumor Cells in Metastatic Triple-Negative Breast CancerCancer Research Communications · 2026
  43. ctDNA Detected after Neoadjuvant Therapy for HER2-Positive Breast Cancer Is Associated with Inferior Outcomes and May Inform Adjuvant TherapyCancer Research Communications · 2026
  44. Aberrant Hippo-YAP/TEAD signaling drives malignant transcriptional reprogramming in external auditory canal squamous cell carcinomaCancer Research Communications · 2026
  45. Clinical Characteristics and Spatial Transcriptome Analysis of Non–Small Cell Lung Cancers Exhibiting Early Alectinib Resistance: A Retrospective OLCSG StudyCancer Research Communications · 2026
  46. Association between Vitamin B12 Levels and Colon Cancer Survival: A Global Network StudyCancer Research Communications · 2026
  47. Treatment Delays and Survival Divides: Race, Sex, and Early-Onset Colorectal Cancer DisparitiesCancer Research Communications · 2026
  48. The Lysine Demethylase KDM4C is an Oncogenic Driver and Regulates ERK Activity in KRAS Mutant Pancreatic Ductal AdenocarcinomaCancer Research Communications · 2026
  49. Combining Brigatinib with mTOR Inhibition to Effectively Treat NF2-SWN–Associated and Sporadic NF2 -Deficient MeningiomasCancer Research Communications · 2025
  50. CCDC6 Immunostaining in Conjunction with the Rad51 HRD Assay May Expand PARPi Treatment Eligibility in Patients with HGSOCCancer Research Communications · 2025